» Articles » PMID: 34067062

Influential Factors of Local Tissue Necrosis After Taiwan Cobra Bites: A Secondary Analysis of the Clinical Significance of Venom Detection in Patients of Cobra Snakebites

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2021 Jun 2
PMID 34067062
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Local tissue swelling, inflammation, and wound necrosis are observed in Taiwan cobra bites. Knowledge of the factors influencing local tissue necrosis after cobra bites might improve the cobra bite treatment strategy. Therefore, we aimed to explore the factors influencing local tissue necrosis after cobra bites. This was a retrospective observational cohort study. All patients clinical presentations including serum venom levels for determining the influential factors in this study were obtained from Hung et al.'s previous study. Clinical features, such as bite information, initial swelling, patient presentation time, serum venom levels, and antivenom, use were extracted. The measurement outcome was the development of wound necrosis. The factors influencing wound necrosis were investigated using univariate and logistic regression analyses. The influential factors of local tissue necrosis and their areas under the curve were: initial limb swelling, 0.88; presentation time × serum level, 0.80; initial necrosis, 0.75; patient presentation time, 0.70. Serum venom level alone cannot be used as a predictive factor. The development of tissue necrosis might be associated with the venom factor, time factor, and their interaction. These influential factors can be used in future studies to evaluate antivenom efficacy.

Citing Articles

Clinical Characteristics of Snakebite Envenomings in Taiwan.

Mao Y, Liu P, Lai K, Luo Y, Chen K, Lai C Toxins (Basel). 2025; 17(1).

PMID: 39852967 PMC: 11769513. DOI: 10.3390/toxins17010014.


Medical management of a child treated for two unique envenomation episodes via captive snakes in a 60-day period: A case report.

Gao M, Zhang X, Jian T, Sun C, Yu G, Gao Y Heliyon. 2025; 10(22):e40245.

PMID: 39748992 PMC: 11693922. DOI: 10.1016/j.heliyon.2024.e40245.


Dermonecrosis caused by a spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib.

Bartlett K, Hall S, Rasmussen S, Crittenden E, Dawson C, Albulescu L Proc Natl Acad Sci U S A. 2024; 121(19):e2315597121.

PMID: 38687786 PMC: 11087757. DOI: 10.1073/pnas.2315597121.


Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms.

Hall S, Rasmussen S, Crittenden E, Dawson C, Bartlett K, Westhorpe A Nat Commun. 2023; 14(1):7812.

PMID: 38097534 PMC: 10721902. DOI: 10.1038/s41467-023-43510-w.


Clinical study of anti-snake venom blockade in the treatment of local tissue necrosis caused by Chinese cobra (Naja atra) bites.

Zeng L, Hou J, Ge C, Li Y, Gao J, Zhang C PLoS Negl Trop Dis. 2022; 16(12):e0010997.

PMID: 36525460 PMC: 9803274. DOI: 10.1371/journal.pntd.0010997.

References
1.
Rivel M, Solano D, Herrera M, Vargas M, Villalta M, Segura A . Pathogenesis of dermonecrosis induced by venom of the spitting cobra, Naja nigricollis: An experimental study in mice. Toxicon. 2016; 119:171-9. DOI: 10.1016/j.toxicon.2016.06.006. View

2.
Mao Y, Liu P, Chiang L, Lai C, Lai K, Ho C . Naja atra snakebite in Taiwan. Clin Toxicol (Phila). 2017; 56(4):273-280. DOI: 10.1080/15563650.2017.1366502. View

3.
Alirol E, Sharma S, Bawaskar H, Kuch U, Chappuis F . Snake bite in South Asia: a review. PLoS Negl Trop Dis. 2010; 4(1):e603. PMC: 2811174. DOI: 10.1371/journal.pntd.0000603. View

4.
Lin J, Sung W, Liao J, Hung D . A Rapid and International Applicable Diagnostic Device for Cobra (Genus ) Snakebites. Toxins (Basel). 2020; 12(9). PMC: 7551368. DOI: 10.3390/toxins12090572. View

5.
Wang W, Chen Q, Yin R, Zhu J, Li Q, Chang H . Clinical features and treatment experience: a review of 292 Chinese cobra snakebites. Environ Toxicol Pharmacol. 2014; 37(2):648-55. DOI: 10.1016/j.etap.2013.12.018. View